• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成反义寡脱氧核苷酸作为抗丙型肝炎的潜在药物。

Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

作者信息

Caselmann W H, Eisenhardt S, Alt M

机构信息

Department of General Internal Medicine, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

Intervirology. 1997;40(5-6):394-9. doi: 10.1159/000150571.

DOI:10.1159/000150571
PMID:9675643
Abstract

Antisense oligodeoxynucleotides (ODNS) can be used to specifically inhibit hepatitis C viral gene expression. Due to its high degree of conservation and its important function as internal ribosomal entry site, the 5'-non-coding region of the hepatitis C virus has been the most effective target to inhibit translation so far. Inhibition of luciferase reporter gene expression of up to 96 +/- 2% has been achieved. Modifications of ODNs like phosphorothioate, methylphosphonate or benzylphosphonate modification of terminal or intramolecular internucleotide phosphates lead to altered lipophilicity and binding stability to its RNA target and resistance against serum nucleases. The mode of action of ODNs is mainly dependent on an efficient induction of RNase H activity. The uptake of ODNs occurs via receptor-mediated or absorptive and fluid-phase endocytosis. After release from the endosomes, ODNs may exert their effects by interaction with cytosolic or nuclear structures. Side effects can occur when this interaction affects intra- or extracellular targets essential for biological cell function. If these problems can be solved, antisense technology has the potential for future therapy of human disease.

摘要

反义寡脱氧核苷酸(ODNs)可用于特异性抑制丙型肝炎病毒基因表达。由于丙型肝炎病毒5'-非编码区具有高度保守性且作为内部核糖体进入位点具有重要功能,因此它一直是迄今为止抑制翻译最有效的靶点。已实现对荧光素酶报告基因表达高达96±2%的抑制。对ODNs进行修饰,如对末端或分子内核苷酸磷酸进行硫代磷酸酯、甲基磷酸酯或苄基磷酸酯修饰,会导致其亲脂性改变以及与RNA靶点的结合稳定性改变,并增强对血清核酸酶的抗性。ODNs的作用模式主要依赖于对RNase H活性的有效诱导。ODNs通过受体介导或吸附及液相内吞作用摄取。从内体释放后,ODNs可通过与胞质或核结构相互作用发挥其效应。当这种相互作用影响生物细胞功能所必需的细胞内或细胞外靶点时,可能会出现副作用。如果这些问题能够得到解决,反义技术在人类疾病的未来治疗中具有潜力。

相似文献

1
Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.合成反义寡脱氧核苷酸作为抗丙型肝炎的潜在药物。
Intervirology. 1997;40(5-6):394-9. doi: 10.1159/000150571.
2
Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).反义胆酸偶联硫代磷酸酯修饰寡脱氧核苷酸抑制丙型肝炎病毒 RNA 翻译。
Antiviral Res. 2013 Jan;97(1):49-59. doi: 10.1016/j.antiviral.2012.10.010. Epub 2012 Nov 6.
3
Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.核心特异性反义硫代磷酸酯寡脱氧核苷酸作为丙型肝炎病毒翻译的强效特异性抑制剂。
Arch Virol. 1997;142(3):589-99. doi: 10.1007/s007050050105.
4
Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.能够抑制丙型肝炎病毒基因表达的硫代磷酸反义寡脱氧核苷酸:体外翻译试验
J Biochem. 1995 Dec;118(6):1199-204. doi: 10.1093/oxfordjournals.jbchem.a125007.
5
In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.化学修饰的反义寡脱氧核苷酸对丙型肝炎病毒基因表达的体外抑制作用
Antimicrob Agents Chemother. 1996 Oct;40(10):2337-44. doi: 10.1128/AAC.40.10.2337.
6
Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence.反义寡脱氧核苷酸对丙型肝炎病毒表达的特异性抑制。用于选择靶序列的体外模型。
J Biol Chem. 1994 May 13;269(19):14205-10.
7
Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.寡核苷酸抑制丙型肝炎病毒 IRES 介导的翻译。
Virus Res. 2009 Dec;146(1-2):29-35. doi: 10.1016/j.virusres.2009.08.008. Epub 2009 Aug 29.
8
Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.
Eur J Clin Invest. 1999 Oct;29(10):868-76. doi: 10.1046/j.1365-2362.1999.00552.x.
9
Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.ISIS 14803(一种丙型肝炎病毒(HCV)内部核糖体进入位点(IRES)的反义寡核苷酸抑制剂)对慢性丙型肝炎患者HCV IRES的病毒学影响以及原发性和继发性HCV耐药性在治疗结果中的潜在作用研究
Antivir Ther. 2004 Dec;9(6):953-68.
10
Oligonucleotide-based therapeutic options against hepatitis C virus infection.基于寡核苷酸的丙型肝炎病毒感染治疗选择。
Antivir Ther. 2006;11(3):273-87.

引用本文的文献

1
Design, delivery and efficacy testing of therapeutic nucleic acidsused to inhibit hepatitis C virus gene expression in vitro and in vivo.用于在体外和体内抑制丙型肝炎病毒基因表达的治疗性核酸的设计、递送及疗效测试。
World J Gastroenterol. 2000 Oct;6(5):626-629. doi: 10.3748/wjg.v6.i5.626.
2
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding.丙型肝炎病毒内部核糖体进入位点(IRES)茎环IIId包含一个对翻译和IRES折叠至关重要的系统发育保守GGG三联体。
J Virol. 2000 Nov;74(22):10430-7. doi: 10.1128/jvi.74.22.10430-10437.2000.